What is Promex?
Promex, established in 1975 and under current management since 1995, is a privately held entity with a deep-rooted history in Silicon Valley. Since pivoting in 2008 to exclusively serve the medical device and biotech sectors, Promex has specialized in providing a low-risk pathway for biotech instrument and medical device companies. Their integrated, U.S.-based component assembly facility in Silicon Valley supports clients from feasibility prototype development through to full-scale production, addressing complex component assembly challenges.
How much funding has Promex raised?
Promex has raised a total of $2.6M across 2 funding rounds:
Debt
$1M
Debt
$1.6M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.6M led by PPP
Key Investors in Promex
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Promex?
The recent major strategic investment signals a period of accelerated growth and potential expansion for Promex. This capital infusion is likely to bolster its capabilities in serving the demanding medical device and biotech markets, potentially enabling further advancements in its component assembly solutions and production capacity. The company's focus on a low-risk, integrated U.S.-based manufacturing process positions it for continued success in a sector requiring high precision and reliability.
See full Promex company page
